Ligand Pharmaceuticals Inc(LGND)股吧_Ligand Pharmaceuticals Inc怎么样

列表
摘要

发新帖

发表新帖
问董秘
发起斗股

阅读	评论	标题	作者	最后更新
59	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	11-12 11:29
64	0	Quarterly report [Sections 13 or 15(d)]	Ligand Pharmaceu资讯	11-09 05:11
55	0	Current report, items 2.02 and 9.01	Ligand Pharmaceu资讯	11-07 08:33
66	0	[Amend] Statement of Beneficial Ownership by Certain Investors	Ligand Pharmaceu资讯	11-02 04:23
102	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	09-26 08:57
109	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	09-25 08:46
111	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	09-25 08:38
103	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	09-24 05:38
111	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	09-24 05:36
128	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	09-21 06:17
126	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	09-21 05:44
92	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	09-20 05:55
80	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	09-19 08:23
166	0	全球骨质疏松用特立帕肽注射液市场报告2024	股友p1266q5579	09-14 04:17
134	0	ALPCO胰岛素ELISA测定程序及结果计算方案	amyjet艾美捷	08-27 04:05
165	0	ALPCO-c肽化学发光ELISA试剂盒，助力测量糖尿病的生物标志物	amyjet艾美捷	09-13 04:13
92	0	ALPCO-c肽(小鼠)ELISA试剂盒，96孔，高精度检测方案	amyjet艾美捷	09-13 04:04
74	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	08-31 09:03
69	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	08-31 09:00
59	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	08-29 04:59
54	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	08-27 08:37
54	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	08-23 09:12
63	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	08-14 05:51
90	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	08-11 04:36
79	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	08-10 05:41
60	0	Quarterly report [Sections 13 or 15(d)]	Ligand Pharmaceu资讯	08-08 04:57
65	0	Current report, items 2.02 and 9.01	Ligand Pharmaceu资讯	08-07 09:35
89	0	Current report, item 5.02	Ligand Pharmaceu资讯	08-03 05:35
416	0	郑州大学宋继中团队：配体补偿可在钙钛矿量子点中实现高效稳定的激子复合，用于高性能 QLED	关注第三代半导体名企	08-02 07:37
61	0	Current report, item 2.01	Ligand Pharmaceu资讯	07-18 05:31
62	0	Current report, items 1.01 and 2.03	Ligand Pharmaceu资讯	07-11 08:57
73	0	Securities to be offered to employees in employee benefit plans	Ligand Pharmaceu资讯	07-10 06:52
65	0	Current report, items 1.01, 7.01, and 9.01	Ligand Pharmaceu资讯	07-08 09:41
82	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	07-03 10:26
76	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	07-03 10:26
78	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	07-03 10:26
79	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	07-03 10:26
66	0	Current report, item 8.01	Ligand Pharmaceu资讯	06-27 09:27
70	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	06-26 05:48
77	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	06-20 08:41
67	0	Current report, item 8.01	Ligand Pharmaceu资讯	06-20 08:39
72	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	06-20 08:34
82	0	Current report, items 5.02 and 5.07	Ligand Pharmaceu资讯	06-18 04:12
184	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	06-18 12:00
190	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	06-18 12:00
184	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	06-18 12:00
182	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	06-18 12:00
71	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	Ligand Pharmaceu资讯	06-04 05:32
77	0	Current report, item 8.01	Ligand Pharmaceu资讯	05-31 05:12
158	0	三优生物与百奥几何全新力作-基于干湿结合的药物结构及功能优化平台	各自观点不同	05-28 03:06
150	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	05-19 04:10
163	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	05-18 08:13
165	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	05-18 07:17
175	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	05-17 05:49
193	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	05-16 08:03
190	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	05-16 06:07
193	0	[Amend] Report of proposed sale of securities	Ligand Pharmaceu资讯	05-16 02:53
195	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	05-15 07:57
207	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	05-14 06:19
199	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	05-14 05:38
448	0	贝莫苏拜单抗获批上市！刷新小细胞肺癌一线治疗OS，带来治疗新选择！	各自观点不同	05-10 08:48
246	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	05-10 06:12
249	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	05-10 06:11
250	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	Ligand Pharmaceu资讯	05-10 04:27
251	0	Quarterly report [Sections 13 or 15(d)]	Ligand Pharmaceu资讯	05-09 05:03
264	0	Current report, items 2.02 and 9.01	Ligand Pharmaceu资讯	05-08 04:17
260	0	Current report, item 1.01	Ligand Pharmaceu资讯	05-07 07:42
322	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	05-03 06:17
436	0	齐鲁制药地舒单抗注射液（鲁达欣）获批上市，引领肿瘤骨改良药物新篇章！	E药经理人	05-01 03:27
329	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	04-27 07:10
275	0	Other definitive proxy statements	Ligand Pharmaceu资讯	04-25 06:21
272	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	Ligand Pharmaceu资讯	04-25 06:21
263	0	Annual Report to Security Holders	Ligand Pharmaceu资讯	04-25 06:20
303	0	营收7年翻7倍，被辉瑞、诺华、吉利德青睐，十亿美元级别的license out鼻祖是如何“养成”的？	E药经理人	04-21 04:14
268	0	Current report, items 5.03 and 9.01	Ligand Pharmaceu资讯	04-20 05:43
310	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	03-28 07:52
369	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	03-08 02:31
371	0	Statement of changes in beneficial ownership of securities	Ligand Pharmaceu资讯	03-07 07:43
382	0	Report of proposed sale of securities	Ligand Pharmaceu资讯	03-06 10:00
402	0	Securities to be offered to employees in employee benefit plans	Ligand Pharmaceu资讯	03-02 05:59

emytylist